A defect in KCa3.1 channel activity limits the ability of CD8 <sup>+</sup> T cells from cancer patients to infiltrate an adenosine-rich microenvironment

Ameet A. Chimote, András Balajthy, Michael J. Arnold, Hannah S. Newton, Péter Hajdú, Julianne Qualtieri, Trisha M. Wise‐Draper, Laura Conforti

Science Signaling · 2018 · 69 citations · 36 references

Concepts

Abstract

T cells to adenosine and the potential therapeutic benefit of KCa3.1 channel activators, which could increase infiltration of these T cells into tumors.

References

36